Navigation Links
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Date:7/9/2009

that are not adequately treated by currently available medicines. LEVADEX inhaled therapy is being developed for the potential treatment of migraine and has completed a successful Phase 3 trial. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

LEVADEX and Tempo are trademarks of MAP Pharmaceuticals, Inc.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to the company's development programs, including MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the development of drug candidates, the conduct and completion of clinical trials, risks related to the failure to achieve favorable clinical outcomes or to have the company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q, filed with the SEC on May 8, 2009, and available at http://edgar.sec.gov.

CONTACT: Christopher Y. Chai, Chief Financial Officer of
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
2. Portola Pharmaceuticals to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update
3. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment
5. Arena Pharmaceuticals Announces Public Offering of Common Stock
6. Solvay Pharmaceuticals, Inc. Announces Commercial Availability of CREON(R) (Pancrelipase) Delayed-Release Capsules
7. Jazz Pharmaceuticals Pays Accrued Interest Under Senior Secured Notes
8. Jazz Pharmaceuticals Completes $7 Million Private Placement
9. Biostar Pharmaceuticals, Inc. Commences the Full Implementation of New Rural Cooperative Supply Network Plan
10. ADVENTRX Pharmaceuticals Announces Closing of Financing
11. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... (PRWEB) November 23, 2014 A new ... its doors in the downtown Greenville area. Dr. Chelsea ... Greenville , decided to open her own clinic after ... results with the patients. , AlignLife believes that ... tools. With a focus on chiropractic care and rehabilitation ...
(Date:11/22/2014)... November 23, 2014 Recently, UWDress.com, a successful ... formal wedding guest attire in order to prepare for ... prices, up to 70% off. , UWDress.com is a ... are very beautiful, especially the new items -- formal wedding ... in the current market, including superstar and princess. As one ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 BambooFlooringChina.com ... the company has proudly released its new collection of ... discounted rates, up to 29% off. , According ... and sturdy tree-like grass, making it a highly renewable resource. ... products have a mixing color which comes from natural bamboo ...
(Date:11/22/2014)... November 22, 2014 “Due to my knee ... inventor, from Gurnee, Ill. “While using the ice grip attachment, ... I thought there needed to be a safer way to ... SPIKE BLOCK. , The SPIKE BLOCK offers added safety and ... would help to reduce injuries and damage associated with traditional ...
(Date:11/22/2014)... Nocturia is defined by the International ... individual has to wake at night one or ... Pipeline Review, H2 2014” provides comprehensive information on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
Breaking Medicine News(10 mins):Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4
... that people are willing to pay up to 29.91 per month, ... surveyed the public in the two major urban centres of Manchester ... to pay in council tax or rent/mortgage payments for green spaces ... pay more for greener spaces with greater tree coverage. Members ...
... family health insurance increased by 50 percent from 2003 ... toward their insurance increased by 63 percent as businesses ... a new Commonwealth Fund report that examines state trends ... insurance costs are outpacing income growth in every state ...
... , WEDNESDAY, Nov. 16 (HealthDay News) -- People who are ... of staving off cancer as well, researchers report. Individuals ... (BMI), normal blood pressure and two to four other "ideal" ... of developing cancer, according to research scheduled for presentation Wednesday ...
... of Medicine and Kyushu University Medical School say a novel ... cell-killing drugs prompts a wide variety of cancer cell types ... death. The findings are reported online in the journal ... is to stop the growth of cancerous cells while doing ...
... can grow for 10 years or longer before currently available ... by Stanford University School of Medicine scientists indicates. The analysis, ... across all solid tumor types, will be published online Nov. ... results can be viewed as both bad and good news," ...
... Aging Society and Services and Advocacy for GLBT ... acclaimed Public Policy & Aging Report (PPAR) on ... policy and research on LGBT older adults, and current and ... "Given the voluminous gerontological literature that has built up over ...
Cached Medicine News:Health News:Public willing to pay more for greener urban spaces 2Health News:Public willing to pay more for greener urban spaces 3Health News:Employer health insurance premiums increased 50 percent in every state from 2003 to 2010 2Health News:Employer health insurance premiums increased 50 percent in every state from 2003 to 2010 3Health News:Employer health insurance premiums increased 50 percent in every state from 2003 to 2010 4Health News:Healthy Heart Habits May Also Guard Against Cancer 2Health News:Healthy Heart Habits May Also Guard Against Cancer 3Health News:New drug combo targets multiple cancers 2Health News:New Stanford model establishes guidelines for earlier cancer detection 2Health News:New Stanford model establishes guidelines for earlier cancer detection 3Health News:New Stanford model establishes guidelines for earlier cancer detection 4Health News:New report highlights LGBT older adults' needs, identifies policy opportunities 2
(Date:11/21/2014)... November 2014 Clementia ... gegeben, dass die Europäische Arzneimittel-Agentur (European ... als Orphan-Medizinprodukt an Palovarotene vergeben hat, ... Behandlung von Fibrodysplasia ossificans progressiva (FOP). ... genetische Krankheit, die von schmerzhaften, wiederkehrenden ...
(Date:11/21/2014)... DUBLIN, Ohio and MELVILLE, N.Y. ... (NYSE: CAH ), one of the world,s ... (NASDAQ: HSIC ), the world,s largest provider ... animal health and medical practitioners, today announced that the ... provide one of the most comprehensive service and product ...
(Date:11/21/2014)... Nov. 20, 2014  Market research firm Kalorama information says ... The Buy, in the medical device industry.  The firm ... will produce just 3% growth this year, which led ... of product lines and entrance by acquisition into new ... medical devices, The Global Market for Medical Devices, ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... 2011 The association representing Montana,s providers of home ... in Congress to repeal the controversial Medicare "competitive" bidding ... "It is imperative that H.R. 1041 pass if ... patients and local businesses in Montana," said Mike Calcaterra, ...
... PARK, N.C., April 12, 2011 Max Neeman meets ... IV metabolic disorder trial across 1200 sites throughout India. ... multiple Phase IV studies for global sponsors with thousands ... across 1500 sites is currently in-process with four more ...
Cached Medicine Technology:Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program 2Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program 3Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program 4Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: